LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective

Evidence supports stereotactic body radiotherapy (SBRT) as a curative treatment option for inoperable early stage non-small-cell lung cancer (NSCLC) resulting in high rates of tumour control and low risk of toxicity. However, promising results are mainly derived from SBRT of peripheral pulmonary les...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Radiol
Main Authors: Adebahr, S, Collette, S, Shash, E, Lambrecht, M, Le Pechoux, C, Faivre-Finn, C, De Ruysscher, D, Peulen, H, Belderbos, J, Dziadziuszko, R, Fink, C, Guckenberger, M, Hurkmans, C, Nestle, U
Formato: Artigo
Idioma:Inglês
Publicado em: The British Institute of Radiology. 2015
Assuntos:
Advances in Radiotherapy Special Feature
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4628529/
https://ncbi.nlm.nih.gov/pubmed/25873481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1259/bjr.20150036
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados